Company: AZN
Filing Date: 2025-09-29
Form Type: 6-K
Source: 0001104659-25-094039
Chunk: 28

Company: ASTRAZENECA PLC
Filing Date: 2025-09-29
Form: 6-K
Chunk 28
---
 such CSN Non-Eligible Certificated Shares directly on the Register. CSN Non-Eligible Certificated Shareholders should note that in circumstances where they are issued a certificate in respect of (and registered as the holder of) CSN Non-Eligible Certificated Shares, subsequent transfers into the DTC clearing system would generally be subject to UK stamp duty or SDRT at the rate of 1.5% of the amount of the consideration given or the value of the shares (if there is no consideration in money or money’s worth given) and may be required to obtain a medallion signature guarantee from an authorised financial intermediary.

Pending completion of an Election Agent Custody Exit Event, (i) any dividends or distributions that become payable in respect of the DTC Eligible Certificated Shares held by CTCNA (in its capacity as custodian of the underlying CSN Non-Eligible Certificated Shares) will accrue for the benefit of, but may not be paid to, the relevant CSN Non-Eligible Certificated Shareholder; and (ii) CSN Non-Eligible Certificated Shareholders will not be able to exercise any voting rights in respect of their underlying CSN Non-Eligible Certificated Shares.

CSN Non-Eligible Certificated Shareholders who elect to hold their AstraZeneca Shares in certificated form or fail to make an election within the Holding Period are expected to be required to submit revised payment preferences in respect of future mandates, preferences elections and instructions as to the payment currency of dividends.

**(d)**

#### Affiliate Shares

#### CTCNA depositary receipt facility
Affiliate Shares will not be eligible for deposit and clearing in DTC because they are not freely tradable pursuant to applicable US federal securities laws and therefore do not meet the relevant eligibility standards provided for in DTC’s applicable rules and procedures.

Accordingly, at the Effective Time, in accordance with Articles 149.5, 149.7 and 149.8 of the New Articles, Affiliate Shares will be transferred to the DR Depositary Nominee as nominee for CTCNA, acting in its capacity as depositary on behalf of the relevant Affiliate Shareholder (the “

#### DR Depositary
”). The DR Depositary will, in its capacity as depositary for such Affiliate Shareholders, issue AstraZeneca DRs to each such Affiliate Shareholder in respect of their underlying entitlement to Affiliate